US health providers and state health departments reject ACIP's updated hepatitis B vaccine guidelines, continuing universal newborn vaccination amid regulatory debate and insurance coverage assurance.

CDC advisory panel updates hepatitis B vaccine guidelines recommending shared clinical decision-making for newborns, while insurance coverage remains intact under ACA and Medicaid mandates.

CDC Advisory Committee updates hepatitis B vaccine recommendations for newborns, introducing shared clinical decision-making while ensuring continued insurance coverage under ACA guidelines.

New Jersey will continue recommending hepatitis B vaccination at birth for newborns, diverging from new federal panel advice suggesting delayed dosing. The state prioritizes early protection to reduce hepatitis B transmission and maintain insurance coverage standards.

CDC's vaccine advisory panel recommends limiting hepatitis B immunization at birth to infants born to hepatitis B positive or unknown status mothers, revising a 30+ year-old universal policy. The decision reflects shifting vaccine guidance and ongoing debates on vaccine safety and dosing.